308nm Excimer Laser Phototherapy System (Targeted Treatment) The 308nm Excimer Laser is a targeted phototherapy device designed for the treatment of skin disorders such as vitiligo, psoriasis, eczema, atopic dermatitis, and leukoderma. It delivers high-energy ultraviolet light directly to affected areas for fast and effective results. Unlike traditional phototherapy, this system uses precise 308nm wavelength technology, allowing targeted treatment of lesions while protecting healthy skin and reducing overall treatment time. Indications Vitiligo Psoriasis Eczema Atopic Dermatitis Leukoderma Specifications Lamp Type: XeCl lamp Wavelength: 308nm Optical Power Density: 30 mW/cm² ±20% Fluence: 30–4200 mJ/cm² Spot Size: up to 16 cm² Treatment Time: 1s–140s Mode: Continuous Size: 27 × 24 × 26 cm Power: 100–240V, 47–63Hz Weight: 9 kg Key Features 308nm single-wavelength excimer technology. . . High precision targeted treatment Fast visible results Large and adjustable spot size for different body areas No consumables, low maintenance cost Handheld and user-friendly design Package Includes 308nm Excimer Laser System Stand Power adapter 6 treatment windows Protective sheet Aluminum carrying case User manual & guide Usage Recommended use is every 2–3 days per treatment. Visible improvement may be seen within 3–10 sessions depending on condition.
Show more ...Looks like there are no reviews for this Product
Looks like there are no reviews for this product
Peninsula is a medical and cosmetic manufacturer integrating research and sales and also a leader in the skin treatment field.Peninsula Medical has 3 factories covering more than 17000m2 areas located in Shenzhen, Chongqing, Hunan in China, with more than 600 employees including 150 R&D team. Peninsula products cover more than 10000 hospitals and medical institutions distributed in more than 70 countries all over the world. By the end of 2021, Peninsula Medical has obtained nearly 70 global certifications such as FDA, CE, and NMPA, and applied for more than 400 domestic and foreign patents, of which nearly 170 have been authorized.